Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2025-11-14 Management Reports
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled 'MANAGEMENT'S DISCUSSION AND ANALYSIS' for Avicanna Inc. for the three and nine months ended September 30, 2025. It contains detailed financial results, operational highlights, and management's commentary on business performance, which is the standard content for an MD&A report. It is not an announcement of a report (RPA) nor a full 10-K, but rather the specific management discussion section often filed as part of quarterly or annual reporting packages.
2025-11-14 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Condensed Consolidated Interim Financial Statements' for Avicenna Inc. for the three and nine months ended September 30, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Operations and Comprehensive Loss, Statement of Changes in Shareholders' Equity, and Statement of Cash Flows) along with detailed notes to the financial statements. It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2025
2025-11-14 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a corporate press release announcing the closing of a non‐brokered private placement offering, detailing the number of units sold, pricing, use of proceeds, warrant terms, and approval conditions—this is clearly a fundraising/capital structure update rather than an earnings release, management discussion, or annual report. It falls squarely under capital/financing activity.
2025-07-16 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release titled “Avicenna Announces Results of Annual General Meeting” and provides detailed vote counts and percentages for director elections and auditor reappointment at the AGM. This is exactly an announcement of shareholder voting results at a general meeting, matching the DVA category.
2025-06-30 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing the Ontario Securities Commission’s revocation of a Management Cease Trade Order. It is not a full report (e.g., annual or quarterly), earnings release, M&A, dividend notice, or governance document, nor does it present new financial results. It does not fit a specific category other than a general regulatory announcement, which falls under the fallback category “Regulatory Filings” (RNS).
2025-04-16 English
Annual information form - English.pdf
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'ANNUAL INFORMATION FORM' (AIF) for the period ended December 31, 2024. In Canadian securities regulation, an Annual Information Form is a disclosure document that provides material information about a company and its business, including corporate structure, risk factors, and regulatory environment. While it is an annual disclosure, it is distinct from the '10-K' (which is a US-specific annual report containing audited financial statements). Since the provided categories include 'Regulatory Filings' as a fallback for documents that do not fit the specific financial report definitions (like 10-K or IR), and AIFs are standard regulatory disclosure documents in Canada, 'RNS' is the most appropriate classification. FY 2024
2025-04-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.